The decision of whether to release transgenic crops in the EU is one subject to flexibility, uncertainty, and irreversibility. We analyse the case of herbicide tolerant sugar beet and reassess whether the 1998 de facto moratorium of the EU on transgenic crops for sugar beet was correct from a cost-benefit perspective using a real option approach. We show that the decision was correct, if households value possible annual irreversible costs of herbicide tolerant sugar beet with about 1 € or more on average. On the other hand, the total net private reversible benefits forgone if the de facto moratorium is not lifted are in the order of 169 Mio € per year.
Introduction
… it is inappropriate to compare the environmental effects of agriculture with GMOs to a nonexistent counterfactual in which agriculture has no negative environmental externalities. (Ando and Khanna, 2000 : 440) The adoption of the first wave of agricultural biotechnology innovations has progressed at a remarkable speed, mainly in the US, Argentina, and Canada (James, 2001) . At the same time, some consumer groups, environmentalists, politicians, and non-governmental organisations oppose the introduction of transgenic crops. The observed divergence of attitudes of different stakeholders in the technology diffusion chain may be the result of a narrow view on technological innovations in the past. For a long time, agricultural technologies have been evaluated, based solely on their private benefit-cost ratio. Much emphasis was put on farm profitability and commodity price declines. In reality, the introduction of new technologies has impacts far beyond the farm or the consumer alone.
Some stakeholders are already absorbing externalities of agricultural technologies: the negative effects or 'costs', e.g. of pesticides, are currently 'paid' for by the environment.
In other words, the private market optimum of agricultural technological innovations does not include any guarantee for sustainability. Therefore, we might want to reconsider the conventional private welfare framework of agricultural innovations by includ ing social values, such as the environment, consumer attitudes and animal welfare, thus transforming it into a social welfare framework. Placing agricultural biotechnology in such a framework implies abandoning the one-dimensional point of view and recognizing the multi-dimensionality of the problem.
Two dimensions of benefits and costs can be distinguished, defining four quadrants of research (Figure 1 ). Uncertainty about benefits and costs can be added as a third dimension. The scope dimension defines whether a researcher is looking at the technology-induced direct market (private) effects, or the external non-market (social) effects (horizontal distribution of effects among stakeholders). The reversibility dimension, on the other hand, looks at long-term sustainability issues (temporal distribution of effects). Reversibility refers to non-additional benefits or costs, after an action has stopped. If a farmer stops planting herbicide tolerant (HT) sugar beets, he can use the fertilizer he bought for other crops and reverse the costs. At the social level, the damages on honeybees can be reversed, if harmful pesticides are banned. In both examples, reversing the action does not include sunk costs. Irreversibility refers to additional benefits or costs, after an action has stopped. If a farmer stops planting sugar beet and has to sell his sugar beet harvester, he may receive a price below the original price after depreciation and can not reverse all the costs. The release of HT sugar beet may have a negative impact on biodiversity resulting in irreversible costs as discussed in chapter two below. At the same time, a net reduction of pesticide use in HT sugar beet will have a positive impact on farmer's health and on biodiversity (Antle and Pingali, 1994, Waibel and Fleischer, 1998) . The pressure on farmer's health and biodiversity of pesticide application are irreversible. If the introduced transgenic crop results in less pesticide application, the introduction provides additional benefits. Hence, the release of transgenic crops produces not only irreversible costs but also irreversible benefits, a term introduced by Pindyck (2000) in the context of greenhouse gas abatement.
Both, the scope and the reversibility dimension are important from an economic point of view as they have an impact on welfare changes. Research quadrant 1 is mainly focused on producer and consumer surplus changes. Private reversible benefits (PRB) comprise pecuniary benefits, such as yield increase and pest control cost decrease as well as non-pecuniary benefits like management savings, increase in flexibility, and convenience value engendered by transgenic crops. Transgenic seeds are supplied by an oligopolistic life sciences sector, and protected by intellectual property rights. This enables the latter to charge an oligopolistic price, which is higher than the price that would prevail in a competitive market. This price mark-up translates into a private reversible cost (PRC) for the farmer. The private welfare increase W is the net effect of both terms. Quadrant 2 falls into the category of reversible social benefits (SRB ) and costs (SRC ). In quadrant 3, social irreversible benefits (R) are categorised, such as e.g. the decline of environmental externalities associated with a technology-induced decrease in pesticide volume and applications. The second component involves the social irreversible costs (I), such as e.g. gene drift, loss of biodiversity, development of herbicide resistance, and negative health externalities, which lack scientific unanimity and certainty. Quadrant 4 comprises effects related to farmers' health, which is especially important for Bacillus thuringiensis (Bt) crops, which generate private irreversible benefits (PIB) through a reduction of poisonous insecticide use. Private irreversible costs ( PIC) would be associated with investments, carrying a fixed-cost element. First wave agricultural biotechnology innovations typically only changed on-farm variable costs, but the introduction of a labelling and identity-preservation system could carry an important irreversible fixed-cost element on farm, processing and distribution sectors. < Insert Figure 1 here. > While the first published US ex post studies concentrate on quadrant 1 (Falck-Zepeda et al., 2000 , Moschini et al., 2000 , the other research quadrants remain poorly covered.
Quadrant 3 and quadrant 4 include irreversibilities, which are important for ex ante studies. The few published ex ante studies on the costs and benefits of transgenic crops either only looked at net private reversible benefits, e.g. Qaim (1999) , or did not include irreversibility, e.g. O'Shea and Ulph (2002) . Hence, after seven years of US experience with commercial biotechnology applications, an important research gap remains largely unfilled, correctly raised by Ando and Khanna (2000: 442) :
Any complete analysis of the environmental impact of these crops and any decision about how to regulate them must take both direct and indirect environmental effects into account.
In this paper, we undertake an initial attempt to approach the problem by focusing on quadrants 1 and 3 looking at the decision of the EU to put a de facto moratorium on transgenic crops. We consider the EU in 1995, one year before the commercial introduction of transgenic crops in US agriculture and reassess whether the decision to approve transgenic herbicide tolerant (HT) sugar beet should be delayed or not.
Incorporating an historical part in our analysis, i.e. the period 1996-2002, draws the attention to the potential benefits, benefits forgone or costs of the 1998 de facto moratorium on transgenic crops by the EU.
The paper is structured as follows. In the first part, we describe the biotechnological innovation of our case study. In the second part, the theoretical model is developed using a real option framework and applied to the EU. Finally, the results are presented and discussed.
Genetically modified herbicide tolerant sugar beet
Effective weed control is essential for economic sugar beet production in all growing areas of the world (Loock et al., 1998) . This was recognized as soon as the crop was first grown (Achard, 1799) . Yield losses can be up to 100%, such is the poor ability of beet to compete with the large range of weeds present in arable soils (Dewar et al., 2000) . A survey on changes in weed control techniques in Europe between 1980 and 1998 revealed that (1) the number of possibilities to control weeds has increased, while (2) the frequency of sprayings increased, (3) the quantity of herbicides per hectare decreased, and (4) weed control techniques shifted gradually from pre-emergence towards postemergence applications, combined with reduced tillage practices (Schäufele, 2000) . The post-emergence herbicides glyphosate and glufosinate-ammonium provide a broader spectrum of weed control in sugar beet than current weed control systems, while at the same time reducing the number of active ingredients used in the beet crop.
Glyphosate was first introduced as an herbicide in 1971. New genetic modification technology has allowed the production of sugar beet tolerant to these herbicides. The gene that confers tolerance to glyphosate was discovered in a naturally occurring soil bacterium. This bacterium produces an enzyme, w hich prevents glyphosate from attacking another enzyme called EPSPS that controls the production of essential amino acids in the plant, without which the plant would die. The gene was isolated using microbiological techniques, and introduced into the beet genome using gene transfer technology.
Glufosinate-ammonium was discovered in 1981. The gene that confers tolerance to glufosinate was also discovered from a naturally occurring soil bacterium and introduced into the beet's genome, accompanied by an antib iotic 'marker' gene that confers resistance to kanamycin to allow the selection of transformed cells in tissue culture (Dewar et al., 2000) . Two commercial HT sugar beet varieties resulted from these genetic insertion techniques: (1) a Roundup Ready™ variety, tolerant to glyphosate and developed by Monsanto, and (2) a Liberty Link™ variety, tolerant to glufosinateammonium and developed by Aventis. These kits composed of a transgenic variety combined with a post-emergence herbicide, offer farmers a number of potential benefits in weed management. Apart from broad-spectrum weed control, it offers flexibility in the timing of applications, compared to the existing programs, and reduces the need for complex compositions of spray solutions. For most growers, herbicide tolerant sugar beet is likely to result in cheaper weed control than current systems .
Moreover, these innovations are entirely coherent with the ongoing trend towards post-emergence weed control and reduced-tillage techniques and the sharpening of the legal constraints for the application of herbicides, especially concerning the protection of the user and the environment (Schäufele, 2000) . It is widely known that pesticide use harms the environment and human health (Waibel and Fleischer, 1998) . Some of these externalities are irreversible. These are long-term health damage, such as chronic diseases from pesticide application and the negative impact of pesticides on biodiversity.
Glyphosate and glufosinate-ammonium have a low toxicity and are metabolized fast and without residues in the soil. As a result, these herbicides have better environmental and toxicological profiles than most of the herbicides they replace Bückmann, 1999, May, 2000) and the introduction of HT sugar beet varieties could provide important social irreversible benefits.
However, pest control strategies based on HT crops potentially entail irreversible environmental externalities, which are, in addition, surrounded by uncertainty. First of all, glyphosate, the herbicide that substitutes for the conventional herbicide mix, has been widely studied for its environmental and human health impacts, extensively documented in Sullivan and Sullivan's (1997) latest compendium of 763 references and abstracts, of which the earlier edition had been criticised by Zammuto (1994) . Secondly, the number of biosafety related publications concerning transgenic organisms has increased within the decade 1990-2000 to more than 3,300 citations according to one of the most comprehensive databases, published online by the ICGEB (2002). Regarding transgenic HT sugar beet systems, their impact on field biodiversity is questioned (Elmegaard and Pedersen, 2001, Gura, 2001 ). However, the major concerns comprise the transfer of genes from transgenic sugar beet by pollen (Saeglitz et al., 2000) to bacteria (Gebhard and Smalla, 1998, Gebhard and Smalla, 1999) or wild relatives (Santoni and Bervillé, 1992 , Boudry et al., 1993 , Fredshavn and Poulsen, 1996 , Madsen et al., 1997 , Dietz-Pfeilstetter and Kirchner, 1998 , Danish EPA, 1999 , Pohl-Orf et al., 1999 , Gestat de Garambe, 2000 , Darmency et al., 2000 , Crawley et al., 2001 , Desplanque et al., 2002 , Bartsch and Schuphan, 2002 ) engendering a hybrid offspring invading farm fields. Most of those studies suggest that field trials cannot predict what will happen once HT crops get into the hands of farmers away from the controlled conditions of an experiment and that still more research is needed in order to get a complete picture of all risks involved.
Theoretical model

Defining the maximum tolerable irreversible costs
The decision to release transgenic crops in the EU is one under flexibility, irreversibility and uncertainty (Wesseler, 2002) . Irreversibility has been discussed. Flexibility exists, as the de-facto moratorium on transgenic crops can be lifted almost any time. Uncertainty exists as future benefits and costs of the technology, like prices and yields, are not known today. Flexibility, irreversibility, uncertainty, and their impact on optimal decision making have been widely analyzed (McDonald and Siegel, 1986 , Pindyck, 1991 , Dixit and Pindyck, 1994 . In comparison to the standard neo-classical decision making criterion where HT sugar beet should be released if the expected net reversible benefits are greater than the net irreversible costs, including irreversibility and uncertainty explicitly, leads to a much higher hurdle rate. The new decision rule is to release HT sugar beet, if the net reversible benefits are greater than the net irreversible costs multiplied by a factor greater than one.
The real option approach allows deriving the new decision rule explicitly. In the literature on real option approaches, the opportunity to act is valued in analogy to a call option in financial markets. The decision maker has the right but not the obligation to exercise an action. This right, the option to act (real option) has a value, which is a result of the option owner's ability to reduce losses by postponing the action, e.g. if new information that arrive over time reveal less than expected net reversible benefits. This is similar to the quasi-option value developed earlier by Arrow and Fisher (1974) and Henry (1974) (Fisher, 2000) . But postponing the decision comes at the opportunity cost of forgone reversible net-benefits for the time being. The decision maker has to compare the benefits of an immediate release with those from a postponed decision, i.e. the value to release later. Only if the benefits of an immediate release, the value of the release, outweigh those of the option to release, should the option to release be exercised.
According to Dixit and Pindyck (1994) Now, if the option to release transgenic crops in the environment, F(W), is exercised, the value of the option to release transgenic crops will be exchanged against the value of net private reversible benefits from transgenic crops in present value terms, W, plus the irreversible benefits, R, minus the irreversible costs, I, of releasing transgenic crops. The objective can be described as maximizing the value of the option to release transgenic crops. Assuming that an asset or a portfolio of assets exists that allows the tracking of the risk of the net private reversible benefits, the arbitrage pricing principle can be applied to value the portfolio that includes the net private reversible benefits from transgenic crops (Pindyck, 1991) . In this case, a portfolio can be constructed consisting of the option to 
A solution to this homogenous second order differential equation is:
, with β 1 > 1 and β 2 < 0.
As the value of the option to release transgenic crops in the environment is worthless if there are no net private reversible benefits, A 2 has to be 0. The other boundary conditions are the 'value matching' (equation 4) and the 'smooth pasting' (equation 5) conditions:
Solving equation 4 according to the boundary conditions provides the following solutions:
( ) 
The result of equation 6 provides the rule that it is optimal to release transgenic crops if the net private reversible benefits are equal to the difference between the irreve rsible costs and benefits multiplied by the factor ( )
. As equation 4 indicates, the full value of releasing transgenic crops in the environment W* not only has to include the irreversible costs and benefits but also the real option value F(W*) of the release.
The irreversible costs and benefits of transgenic crops are highly uncertain as explained before. Nevertheless, in the following it will be assumed that they are known with certainty. The relevance of uncertainty about irreversible costs can be reduced by solving equation 6 for the irreversible costs. This provides:
Instead of identifying the net private reversible benefits required to release transgenic crops in the environment, the maximum tolerable irreversible costs under given net private reversible benefits are identified. If net private reversible benefits can be identified, a space can be designed showing areas of rejection and approval of releasing transgenic crops.
Defining the net private reversible benefits W
Estimates for W are obtained using the model 'EUWABSIM' developed by Demont and Tollens (forthcoming) . This is a partial equilibrium model assessing the welfare effects in the sugar output market due to the introduction of transgenic sugar beet. The model is based on the large open-economy framework of Alston et al. (1995) , but explicitly recognizes that research protected by intellectual property rights generates monopoly profits (Moschini and Lapan, 1997) . It is framed to the policy and market features of the EU Common Market Organization (CMO) for sugar (Bureau et al., 1997 , Combette et al., 1997 3 During the agricultural seasons 1996/97-2000/01, cane sugar and beet sugar accounted, on average, for 71% and 29% of global sugar production respectively. The EU is the world's largest beet sugar producer, responsible for half of global beet sugar supplies, and the largest sugar exporter together with Brazil, exporting each 20% of the world's traded sugar (Demont and Tollens, forthcoming) .
The differentials between aggregate supply and demand functions result in an EU export supply function and a ROW export demand function, since the EU is a net exporter and the ROW a net importer of sugar. By imputing a hypothetical adoption curve for HT sugar beet into the model, the technology-specific parameters engender a pivotal shift of the regional NLCE supply functions and hence of the export supply and demand functions. The world price is modelled as the intersection of both functions on the world market. Changes in the world price are transmitted to domestic EU prices through the auto -financing constraint of the CMO for sugar (Combette et al., 1997) . Finally, the welfare changes (producer and consumer surplus) are calculated via standard procedures (Just et al., 1982 
The 1995 present value of the social irreversible benefits R 95,i can be written as:
The motivation for choosing the risk adjusted rate of return is that the risk of the additional benefits could be tracked with a dynamic portfolio of market assets:
, where r is the risk-free interest rate, φ the market price of risk, σ the variance parameter, and ρ bm the coefficient of correlation between the asset or portfolio of assets that track W and the whole market portfolio. See Dixit and Pindyck (1994: 147 -150) for an elaboration of this assumption.
Data
Since HT sugar beet are not yet adopted we estimate the adoption parameters of a comparable technology in the US, i.e. HT Roundup Ready™ soybeans (FernandezCornejo and McBride, 2002) .
6 Therefore, we first transform equation 10 into its loglinear form: Estimates for the net private reversible benefits are generated by EUWABSIM. Due to the CMO for sugar, which fixes domestic prices at the beginning of each marketing year, no increases in consumer surplus are found for the EU despite the introduction of HT sugar beet. The net private reversible benefits in the EU consist only of a domestic 6 We believe that the US case of HT Roundup Ready™ soybeans is comparable to the EU case of HT sugar beet, because of (1) the common embedded technology of herbicide tolerance, (2) the ubiquitous importance of each crop on both continents, and (3) the importance of exports of the refined products. ? max,i = 75% and taking the maximum of the five estimates (i = 1, …, 5).
(2) loss of biodiversity due to the application of pesticides in agriculture 9
, we obtain social costs of 0.87 €/kg AI for the UK, 0.88 €/kg AI for the US, and 0.69 €/kg AI for
Germany. For our analysis, we use the third estimate as a conservative proxy for the social costs of pesticide use. The change in the number of weeding applications, ?n i , is calculated by taking the difference in the number of applications between conventional (Schäufele, 2000) and HT sugar beet farming (Bückmann et al., 2000) . 10 Rasmusson ( For estimating he drift rate α and the variance rate σ of the new technology 'herbicide tolerance', we compute the maximum likelihood estimator assuming continuous growth (Campbell et al., 1997: Chapter 9. 3). We use historical data on annual gross margin differentials in sugar beet production from 1973 up to 1995 as a proxy for estimating the 9 One might argue the water control costs for pesticides should be included. We did not consider them, as the pesticides used in HT and non-HT sugar beet are also used on other crops and the water authorities have to continue testing the water, regardless of the adoption of the new technology.
growth and variance characteristics of the underlying 'weeding technology path'. The data are extracted from the EU/SPEL dataset (Euro stat, 1999) for all EU-15 Member
States and deflated and converted into real terms using the GDP deflators published by the World Bank (2002). The country-specific hurdle rate is calculated using the estimated drift and variance rate per country and choosing a risk-free rate of return, r, of 4.5% and a risk-adjusted rate of return, µ, of 10.5% for all countries. Finally, data on areas planted to sugar beet, numbers of sugar beet holdings, and currency rates are extracted from the AGRIS dataset (Eurostat, 2002) , w hile household data are reported by the EEA (2001). whether the average willingness to accept the perceived loss of biodiversity due to the introduction of HT sugar beet would be inferior to this threshold. This is in line with the observed reluctant attitude of EU citizens regarding transgenic crops and the extent to which this translates into a relatively high willingness to pay to avoid these products. Burton et al. (2001) show the relative importance of different aspects of the food system in forming preferences, and that transgenic food is only one of a number of concerns, albeit a significant one. Finally, if we distribute the cost among the 'responsible' sugar beet growers, as if the externality remained on the farm, logically much higher values are found. The total net private reversible benefits forgone if the de facto moratorium is not lifted are in the order of 169 Mio € per year.
Results and discussion
Conclusion
In this paper we showed the multi -dimensional features of cost-benefit analysis on genetically modified crops. While most literature on the economic impact of transgenic crops remains entirely focused on the estimation of net private reversible benefits, our study tries to fill a gap in literature, by assessing the social irreversible benefits and costs of a biotechnology innovation in the sugar industry. Historical time serie s data on gross margins allows us to estimate the maximum tolerable social irreversible costs, given the net private reversible benefits estimated in ex ante using the model by Demont and 
